Aptiv price target lowered to $100 from $105 at Barclays

Barclays lowered the firm’s price target on Aptiv to $100 from $105 and keeps an Overweight rating on the shares post the Q2 report. The company’s “robust? margin beat reinforces a solid trajectory but the guidance was cut as expected, the analyst tells investors in a research note.